 |
Altogen Biosystems 848 Rainbow Blvd #823 Las Vegas, NV 89107 United States Phone: (702) 989-0841 Fax: (702) 989-0841 Website: www.altogen.com E-mail: orders@altogen.com Altogen Biosystems is a life sciences company dedicated to the development and manufacturing of the cell line specific transfection reagents. Pre-optimized transfection kits enable efficient delivery of plasmid DNA, mRNA, siRNA, and microRNA into broad range of cell types and primary cells. Advanced formulation of reagents and peculiar design of the transfection protocols provides reproducible results. Transfection agents are serum compatible, induce low toxicity, and can be used for co-transfection experiments and high-throughput applications. Transfection, an introduction of foreign DNA or RNA molecules into cultured cells, is now a commonly used method in biological laboratories for studying gene function, modulation of gene expression, biochemical mapping, mutational analysis, and protein production. Scientists use various carrier molecules to enable non-viral gene delivery of such molecules as plasmid DNA (pDNA), messenger RNA (mRNA), short interfering RNA (siRNA), and microRNA (miRNA) into cancer cell lines and primary cells. Unfortunately, there is no single delivery method or transfection agent that can be applied to all types of cells: transfection efficiencies vary dramatically depending on which cell type is being transfected, and what reagent is used. Altogen Biosystems offers pre-optimized transfection technologies for a specific cell line by applying expertise in combinatorial chemistry, molecular biology, and cell biology. Successfully transfected cell lines include: Aortic smooth muscle cells (ASMC), human lung carcinoma cells (A549), human hepatocellular carcinoma cells (HepG2), human prostate cancer cells (DU145), mouse embryonic stem cells (MES), human rhabdomyosarcoma cells (A204), human epithelial kidney cells (HEK293), hamster ovary epithelial cells (CHO), human trachea epithelium cells (CFPEo), human hypopharyngeal carcinoma cells (FaDu), human coronary artery endothelial cells (HCAEC), human cortical neuronal cells (HCN-1A), human cervix adenocarcinoma cells (HeLa), umbilical vein endothelial cells (HUVEC), breast cancer cells (MDA-MB), murine embryonic fibroblast cells (MEF), human diploid fibroblast cells (MRC-5), rat pheochromocytoma cells (PC12), human adrenocortical carcinoma cells (SW-13), and others. View Product Categories |
|
Product: HepG2 Transfection Reagent Catalog #: 2067 Price: US$195 Link: http://www.altogen.com Benefits: Pre-Optimized Transfection Kits for Over 60 Cell Lines and Primary Cells Description:
|
 |